• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
Home
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Pharma
    • Asia
    • Drug Delivery
    • Executives
    • Clinical Data
  • Vaccines
  • Special Reports
  • Trending
    • COVID-19
    • Cell & Gene Therapy
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
Search Icon
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Pharma
    • Asia
    • Drug Delivery
    • Executives
    • Clinical Data
  • Vaccines
  • Special Reports
  • Trending
    • COVID-19
    • Cell & Gene Therapy
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events

chronic kidney disease

Pharma

GSK's anemia drug Jesduvroq scores FDA green light

The FDA approved the drug for patients who are on dialysis. Safety in the non-dialysis patient population "has not been established," the agency said.
Zoey Becker Feb 2, 2023 8:30am

AZ targets people who don't know they have CKD in new spot

Jan 27, 2023 7:30am

Unicycive's pivotal trial of Takeda kidney drug rival hits goal

Jan 3, 2023 7:30am

Travere teams up with patient groups for new kidney campaign

Nov 21, 2022 7:55am

After pair of losses, Ardelyx's CKD prospect finds FDA foothold

Nov 17, 2022 8:05am

FDA flags concerns about Ardelyx's kidney disease prospect

Nov 15, 2022 10:48am
Home
  • Connect
    • The Team
    • Advertise
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2023 Questex LLC All rights reserved.
Terms of use
Privacy Policy